Harrow, Inc. (HROW)
28.44
+0.29
(+1.03%)
USD |
NASDAQ |
Oct 23, 16:00
28.43
-0.01
(-0.04%)
After-Hours: 20:00
Harrow Enterprise Value : 1.283B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.283B |
| October 22, 2026 | 1.272B |
| October 21, 2026 | 1.275B |
| October 20, 2026 | 1.269B |
| October 19, 2026 | 1.254B |
| October 16, 2026 | 1.239B |
| October 15, 2026 | 1.294B |
| October 14, 2026 | 1.238B |
| October 13, 2026 | 1.275B |
| October 12, 2026 | 1.308B |
| October 09, 2026 | 1.317B |
| October 08, 2026 | 1.361B |
| October 07, 2026 | 1.364B |
| October 06, 2026 | 1.354B |
| October 05, 2026 | 1.363B |
| October 02, 2026 | 1.359B |
| October 01, 2026 | 1.364B |
| September 30, 2026 | 1.371B |
| September 29, 2026 | 1.394B |
| September 28, 2026 | 1.401B |
| September 25, 2026 | 1.456B |
| September 24, 2026 | 1.457B |
| September 23, 2026 | 1.476B |
| September 22, 2026 | 1.508B |
| September 21, 2026 | 1.488B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.456B |
| September 17, 2026 | 1.458B |
| September 16, 2026 | 1.499B |
| September 15, 2026 | 1.485B |
| September 14, 2026 | 1.494B |
| September 11, 2026 | 1.509B |
| September 10, 2026 | 1.588B |
| September 09, 2026 | 1.624B |
| September 08, 2026 | 1.635B |
| September 04, 2026 | 1.661B |
| September 03, 2026 | 1.651B |
| September 02, 2026 | 1.680B |
| September 01, 2026 | 1.602B |
| August 31, 2026 | 1.600B |
| August 28, 2026 | 1.614B |
| August 27, 2026 | 1.661B |
| August 26, 2026 | 1.691B |
| August 25, 2026 | 1.766B |
| August 24, 2026 | 1.708B |
| August 21, 2026 | 1.751B |
| August 20, 2026 | 1.793B |
| August 19, 2026 | 1.777B |
| August 18, 2026 | 1.698B |
| August 17, 2026 | 1.696B |
| August 14, 2026 | 1.717B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Viatris, Inc. | 33.01B |
| 60 Degrees Pharmaceuticals, Inc. | 10.92M |
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.27M |
| Revenue (Quarterly) | 70.66M |
| Total Expenses (Quarterly) | 87.93M |
| EPS Diluted (Quarterly) | -0.4624 |
| Gross Profit Margin (Quarterly) | 71.27% |
| Profit Margin (Quarterly) | -24.44% |
| Earnings Yield | -3.51% |
| Operating Earnings Yield | 0.53% |
| Normalized Earnings Yield | -2.465 |